|
Gimeno L, Martinez-Banaclocha H, Bernardo MV, Bolarin JM, Marin L, Lopez-Hernandez R, Lopez-Alvarez MR, Moya-Quiles MR, Muro M, Frias-Iniesta JF, Martinez-Escribano J, Alvarez-Lopez MR, Minguela A, Campillo JA. NKG2D Polymorphism in Melanoma Patients from Southeastern Spain. Cancers (Basel). 2019 Mar 28;11(4):438. doi: 10.3390/cancers11040438. PubMed PMID: 30925758; PubMed Central PMCID: PMC6521179.
AÑO: 2019; IF: 6.126
|
|
Mesa-del-Castillo, B. P.; Alcaniz Rodiguez, Paula; Blazquez, Ana; Castellon Perez, Marta; Salvador Garcia, Carme; Menasalvas Ruiz, Ana; Alfayate Minguelez, Santiago; Mira Requena, Encarna; Gimeno Arias, Lourdes. Septic Osteoarthritis Due to Streptococcus dysgalactiae Subspecies equisimilis in a Three-Year-Old Girl. ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES. APR 2016; 4(2). 10.5812/pedinfect.33831
AÑO: 2016
|
|
Gimeno L, Serrano-Lopez EM, Campillo JA, Canovas-Zapata MA, Acuna OS, Garcia-Cozar F, Martinez-Sanchez MV, Martinez-Hernandez MD, Soto-Ramirez MF, Lopez-Cubillana P, Martinez-Escribano J, Martinez-Garcia J, Corbalan-Garcia S, Alvarez-Lopez MR, Minguela A. KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling. Cancers (Basel). 2020 Oct 15;12(10):2991. doi: 10.3390/cancers12102991. PubMed PMID: 33076479; PubMed Central PMCID: PMC7650600.
AÑO: 2020; IF: 6.639
|
|
Bernal E, Gimeno L, Alcaraz MJ, Quadeer AA, Moreno M, Martinez-Sanchez MV, Campillo JA, Gomez JM, Pelaez A, Garcia E, Herranz M, Hernandez-Olivo M, Martinez-Alfaro E, Alcaraz A, Munoz A, Cano A, McKay MR, Muro M, Minguela A. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019. J Infect Dis. 2021 Jul 15;224(2):229-240. doi: 10.1093/infdis/jiab228. PubMed PMID: 33928374; PubMed Central PMCID: PMC8135764.
AÑO: 2021; IF: 7.759
|
|
Vasco-Mogorron MA, Campillo JA, Periago A, Cabanas V, Berenguer M, Garcia-Garay MC, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, Muro M, Minguela A. Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms. Int J Mol Sci. 2021 Apr 9;22(8):3895. doi: 10.3390/ijms22083895. PubMed PMID: 33918790; PubMed Central PMCID: PMC8068942.
AÑO: 2021; IF: 6.208
|